This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Donors of organs and tissues
Z21_DONORS_ORGANS_TISSU
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
503 |
4. Check minimum number of eventsNone |
503 |
5. Include endpointsNone |
503 |
6. Filter based on genotype QC (FinnGen only) |
503 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z4|Z5[0-4]
Similar endpoints
↥List of similar endpoints to
Donors of organs and tissues
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 503 | 290 | 213 |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | 48.62 | 47.20 | 50.56 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 445
- Matched controls
- 4449
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z52.4
ICD-10 Finland
Kidney donor
+∞
183.3
163
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
134.3
122
*
Z00.5
ICD-10 Finland
Examination of potential donor of organ and tissue
+∞
123.9
113
*
WW409
NOMESCO Finland
Other aferesis
312.9
100.1
98
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
458.9
79.5
77
*
L03AA02
ATC
filgrastim; parenteral
56.9
77.6
91
20
Z52.9
ICD-10 Finland
Donor of unspecified organ or tissue
+∞
76.3
71
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
24.5
71.4
103
54
WW300
NOMESCO Finland
Transfer of autologic stem cells
145.0
70.2
73
6
Z52.3
ICD-10 Finland
Bone marrow donor
+∞
68.5
64
*
YKA01
NOMESCO Finland
Percutaneous endoscopic excision of kidney from living donor
+∞
56.5
53
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
28.4
49.8
68
28
C90.0
ICD-10 Finland
Multiple myeloma
39.0
46.1
58
17
XW000
NOMESCO Finland
Bone marrow biopsy
13.5
44.6
80
71
153
Kela drug reimbursment
Lenalidomid
69.4
38.9
44
7
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.3
37.6
111
224
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
35.9
34
*
L04AX04
ATC
lenalidomide; oral
64.2
35.8
41
7
WW500
NOMESCO Finland
Blood transfusion
19.2
34.6
53
31
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
47.3
29.1
35
8
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.9
28.9
54
51
M04AA01
ATC
allopurinol; systemic
6.5
28.4
78
140
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
50.7
27.8
33
7
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
103.1
27.0
29
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.6
26.8
60
79
H02AB02
ATC
dexamethasone; systemic
5.9
26.7
80
160
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
29.1
26.2
35
13
J05AB11
ATC
valaciclovir; oral
4.6
25.6
97
252
329
Kela drug reimbursment
Lenalidomide
53.4
25.6
30
6
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
26.2
24.7
34
14
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
18.2
24.0
37
22
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
22.3
197
975
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.0
21.9
56
90
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.5
21.1
115
407
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
26.0
19.8
27
11
A04AA01
ATC
ondansetron; systemic, rectal
5.9
18.4
53
100
L03AA13
ATC
pegfilgrastim; parenteral
8.6
17.9
39
49
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
99.0
17.7
19
*
AA1AA
NOMESCO Finland
Head X-ray examination
26.8
17.1
23
9
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
11.4
15.7
29
27
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
20.9
15.2
22
11
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.0
15.1
42
76
Z52.8
ICD-10 Finland
Donor of other organs and tissues
+∞
14.7
14
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
82.8
14.7
16
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
77.5
13.7
15
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
35.2
13.6
17
5
KA1FN
NOMESCO Finland
Isotope renography
17.4
13.1
20
12
N02AA05
ATC
oxycodone; systemic
3.7
13.0
59
177
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
71.9
12.7
14
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
25.1
12.5
17
7
JN4AD
NOMESCO Finland
Body CT examination
4.5
12.5
45
109
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
12.3
54
157
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.3
12.0
26
33
JN4BD
NOMESCO Finland
Extensive body CT
3.6
11.4
53
162
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
7.9
10.8
24
32
PJA10
NOMESCO Finland
Exploration of lymph nodes
12.4
10.4
18
15
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
13.5
10.2
17
13
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
41.0
10.0
12
*
B03XA02
ATC
darbepoetin alfa; parenteral
26.7
9.9
13
5
J01MA12
ATC
levofloxacin; systemic
2.6
9.9
79
346
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
9.7
61
232
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.0
9.4
54
193
Z52.2
ICD-10 Finland
Bone donor
+∞
9.4
9
*
YKA00
NOMESCO Finland
Excision of kidney from living donor
+∞
9.4
9
*
R4110
NOMESCO Finland
Physiotherapy
2.2
9.0
103
537
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
6.3
9.0
23
38
WF049
NOMESCO Finland
Radiotherapy of metastasis
12.9
8.9
15
12
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
51.0
8.7
10
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
8.4
85
418
J02AC03
ATC
voriconazole; systemic
91.7
8.4
9
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
91.7
8.4
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.8
8.4
17
20
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
+∞
8.4
8
*
R50.9
ICD-10 Finland
Fever, unspecified
2.4
7.9
67
302
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
6.6
7.8
19
30
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.1
7.7
29
75
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
25.5
7.6
10
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.5
7.5
25
58
L04AX02
ATC
thalidomide; oral
81.3
7.4
8
*
J05AB01
ATC
aciclovir; systemic
2.0
7.2
93
508
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
30.5
7.2
9
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
30.5
7.2
9
*
NB6AA
NOMESCO Finland
Humerus X-ray examination
9.0
7.1
14
16
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.1
6.9
25
63
JN6AD
NOMESCO Finland
CT of torso and neck
8.5
6.9
14
17
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
6.9
53
227
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
6.5
34
116
JN4DD
NOMESCO Finland
Scout CT scan of torso
70.8
6.4
7
*
Z51.6
ICD-10 Finland
Desensitization to allergens
+∞
6.3
6
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
+∞
6.3
6
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
27.1
6.2
8
*
TGC00
NOMESCO Finland
Bronchial lavation
5.3
6.1
17
33
127
Kela drug reimbursment
Transplant complication
10.2
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
200
40
82.34
307.65
1.6
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
220
71
54.30
307.65
1.7
1.2
u/ml
10.7
—
—
6
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
209
44
80.56
307.65
3.2
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
223
71
55.63
307.65
1.7
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
236
86
50.81
307.65
1.9
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
243
162
28.08
297.80
1.9
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
186
81
35.85
270.42
1.8
1.2
u/ml
212.6
231.8
0.26
117
49
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
166
67
36.49
246.82
1.6
1.2
u/ml
119.6
112.1
0.32
37
14
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
122
27
59.33
212.79
1.9
7.9
—
47.8
—
0
9
(3021879) Hepatitis B virus core Ab [Presence] in Serum
277
385
14.79
212.56
1.9
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
307
584
11.92
180.29
2.2
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
85
10
102.08
163.49
3.4
2.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
85
10
102.08
163.49
3.4
2.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
85
10
102.08
163.49
3.4
2.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
86
12
86.24
161.65
3.4
2.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
86
12
86.24
161.65
3.4
2.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
86
12
86.24
161.65
3.4
2.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
86
12
86.24
161.65
3.4
2.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
94
25
46.01
155.79
3.7
4.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
77
14
64.76
138.15
1.5
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
86
28
36.84
134.35
3.4
2.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
86
28
36.84
134.35
3.4
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
86
28
36.84
134.35
3.4
2.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
111
71
19.78
133.26
6.1
4.6
iu/ml
374.5
292.4
—
22
9
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
79
20
46.67
132.02
3.8
2.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
86
32
32.21
128.69
3.5
2.3
—
—
—
0
0
(4306422)
104
63
20.55
128.02
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
88
36
29.42
127.43
3.5
2.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
312
852
8.01
122.41
2.3
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
119
8
194.14
118.10
2.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
88
45
23.49
116.57
3.5
1.9
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
77
29
31.17
114.44
4.7
3.8
%
61.3
56.5
0.34
69
16
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
136
166
10.86
108.88
1.2
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
119
124
12.26
106.56
1.3
1.7
%
102.5
91.3
4.19
113
117
(3019832) Treponema pallidum Ab [Presence] in Serum
252
639
6.90
103.62
2.0
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
81
45
21.26
103.16
4.6
3.9
%
1.8
0.9
1.43
73
34
(21494890) Protein electrophoresis panel - 24 hour Urine
65
20
37.17
102.62
3.6
3.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
92
68
16.33
101.58
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
61
16
43.25
100.48
6.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
107
106
12.55
98.84
5.2
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
323
1075
6.60
97.45
2.5
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
61
18
38.43
97.34
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
90
70
15.44
96.43
3.5
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
276
809
6.34
95.65
5.1
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
90
71
15.22
95.62
3.5
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
99
95
12.73
93.19
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
87
70
14.82
91.26
1.1
1.2
u/ml
2.6
3.3
0.32
35
29
(3036489) Thrombin time
112
133
10.55
90.74
1.2
1.8
s
19.5
21.3
2.46
80
118
(3025468) Yersinia sp identified in Specimen by Organism specific culture
71
39
21.03
90.61
2.8
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
71
40
20.50
89.55
2.9
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
71
40
20.50
89.55
2.9
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
71
40
20.50
89.55
2.9
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
71
40
20.50
89.55
2.9
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
69
40
19.83
85.81
2.9
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
76
55
16.10
84.46
2.5
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
59
26
25.57
82.31
1.4
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
82
72
13.41
81.34
1.1
1.2
u/ml
2.4
4.0
0.28
20
28
(3022313) Gas panel - Capillary blood
99
125
9.62
76.00
6.4
2.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
295
1082
5.17
74.19
5.5
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
67
49
15.62
73.80
16.9
4.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
65
46
16.08
72.87
10.9
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
108
172
7.72
67.88
5.9
2.7
mmol/l
1.4
1.7
0.46
93
118
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
86
105
9.67
67.49
3.3
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
108
180
7.37
64.97
6.1
2.7
ph
7.4
7.4
—
5
25
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
68
64
12.13
64.14
18.7
4.3
—
1.3
—
0
6
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
71
73
11.16
63.07
2.9
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
46
21
24.01
62.98
3.8
2.4
e6/l
677.5
561.1
0.40
46
15
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
347
1589
4.82
62.01
20.3
5.3
mmol/l
1.2
1.2
0.20
321
1354
(40765089) Chromosome analysis panel - Blood by G-banded
49
27
20.00
61.96
1.0
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
291
1173
4.51
61.79
8.3
5.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
50
29
19.03
61.75
3.9
2.3
e9/l
0.9
1.3
—
5
16
(3048879) Bone marrow aspiration report
66
7
108.29
61.54
3.1
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
323
1435
4.50
59.29
11.9
4.8
mmol/l
1.2
1.2
0.10
314
1305
(3032080) INR in Blood by Coagulation assay
289
1195
4.33
58.39
5.7
5.7
inr
1.1
1.1
0.07
37
389
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
134
313
5.47
56.45
1.6
2.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
60
8
84.68
54.36
2.5
1.0
—
—
—
0
0
(4268621)
54
46
13.03
54.06
2.0
2.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
59
8
83.10
53.32
2.5
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
59
8
83.10
53.32
2.5
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
59
8
83.10
53.32
2.5
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
122
275
5.54
53.30
5.5
4.9
%
0.0
0.2
1.32
79
75
(3002179) Metamyelocytes/100 leukocytes in Blood
120
270
5.52
52.48
5.5
4.7
%
1.1
0.5
1.69
69
59
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
106
214
6.01
52.17
2.6
2.9
ng/l
61.6
69.8
0.92
99
194
(3019225) pH of Specimen
128
307
5.25
52.00
21.2
3.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
126
307
5.14
50.12
15.6
4.4
u/l
214.8
233.0
1.33
121
292
(3017181) Myelocytes/100 leukocytes in Blood
122
292
5.20
49.52
5.5
4.8
%
0.9
0.9
0.05
79
86
(3022096) Basophils/100 leukocytes in Blood
338
1691
4.04
49.17
9.3
5.9
%
0.7
0.7
0.03
328
1583
(3023520) Reticulocytes [#/volume] in Blood
102
214
5.72
47.97
3.6
2.6
e9/l
60.7
71.8
3.18
91
161
(3006504) Eosinophils/100 leukocytes in Blood
343
1758
3.99
47.54
9.3
5.8
%
2.8
2.9
0.57
334
1645
(3019069) Monocytes/100 leukocytes in Blood
343
1768
3.96
46.90
9.7
6.2
%
8.9
8.3
2.91
334
1667
(3002030) Lymphocytes/100 leukocytes in Blood
350
1841
3.96
46.12
9.3
5.8
%
29.6
29.6
0.01
339
1731
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
337
1731
3.87
46.00
7.1
3.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
348
1831
3.92
45.66
7.8
5.6
%
54.2
55.9
2.34
336
1731
(3024561) Albumin [Mass/volume] in Serum or Plasma
290
1358
3.68
45.56
6.9
4.2
g/l
36.8
37.3
0.79
282
1274
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
94
194
5.73
44.87
3.0
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
349
1892
3.76
42.54
7.7
5.8
e9/l
0.5
0.6
1.93
307
1664
(3006315) Basophils [#/volume] in Blood
350
1903
3.76
42.42
7.9
5.8
e9/l
0.0
0.0
3.88
307
1670
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
154
494
4.05
42.33
2.8
2.4
e6/l
3.5
2.6
0.51
87
261
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
47
7
73.80
41.83
1.0
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
356
1969
3.76
41.73
8.1
6.2
e9/l
0.2
0.2
2.64
312
1749
(3019198) Lymphocytes [#/volume] in Blood
356
1975
3.75
41.39
7.6
5.8
e9/l
1.7
2.0
4.25
317
1767
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
48
9
58.72
41.28
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
38
29
14.09
40.39
1.4
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
37
27
14.71
40.33
1.3
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
158
532
3.87
40.30
2.7
2.3
e6/l
0.7
0.9
0.21
96
295
(3026493) Urate [Moles/volume] in Serum or Plasma
217
900
3.48
40.17
3.4
2.3
umol/l
306.9
6415.7
3.57
206
810
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
258
1194
3.38
39.87
3.9
2.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
142
448
4.02
39.71
4.5
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
46
9
56.08
39.27
3.8
2.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
75
144
5.95
38.45
2.8
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
227
992
3.35
38.21
3.6
2.5
e6/l
11.8
78.4
3.14
191
744
(3045142) Bone marrow Pathology biopsy report
36
31
12.43
35.53
1.3
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
210
908
3.25
35.47
3.3
2.5
e6/l
0.1
0.4
1.70
165
667
(3005719) IgG [Mass/volume] in Serum or Plasma
108
306
4.22
34.68
12.5
2.5
g/l
8.7
10.7
4.83
101
280
(3004588) Protein electrophoresis panel - Serum or Plasma
77
167
5.26
34.43
18.1
2.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
41
9
49.46
34.30
2.2
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
94
244
4.51
33.81
3.3
1.6
g/l
1.0
1.3
0.71
73
226
(3013650) Neutrophils [#/volume] in Blood by Automated count
364
2211
3.34
33.15
14.8
8.5
e9/l
3.2
3.9
12.07
322
1939
(3003694) ABO and Rh group [Type] in Blood
248
1227
3.01
32.42
1.6
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
96
263
4.28
32.11
4.4
5.0
%
0.0
0.1
0.59
71
59
(3020682) Albumin/Creatinine [Ratio] in Urine
214
984
3.04
31.80
3.2
3.9
mg/mmol
11.2
9.6
0.09
118
627
(3018095) Leukocytes [#/volume] in Urine
246
1224
2.98
31.63
4.4
2.9
e6/l
59.8
104.6
0.32
197
811
(3033658) Prothrombin time (PT) actual/Normal
195
860
3.07
31.08
2.5
3.4
%
98.9
95.4
1.19
189
840
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
75
174
4.89
30.89
1.4
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
37
41
9.66
30.72
1.1
1.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
129
447
3.54
30.68
2.6
1.9
s
27.6
29.3
3.28
124
435
(36304419) Bacteria [Presence] in Urine
201
915
2.99
30.10
3.2
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
201
935
2.91
28.67
2.9
3.2
mg/l
43.5
276.8
1.23
108
607
(3037467) Urinalysis macro (dipstick) panel - Urine
395
2650
3.28
27.72
4.9
3.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
31
32
10.26
27.03
2.8
2.0
%
29.5
38.0
—
14
5
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
70
6.79
26.98
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
54
109
5.43
25.98
1.8
3.6
g/l
0.7
0.3
1.27
30
52
(3009508) Creatinine [Moles/volume] in Urine
219
1111
2.72
25.90
2.7
3.0
mmol/l
7.6
8.3
1.48
211
951
(3034426) Prothrombin time (PT)
23
16
15.02
25.50
1.1
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
90
283
3.66
24.46
2.6
2.0
ml/min/173m2
63.1
76.1
3.25
42
113
(3036603) Volume of Urine
26
24
11.37
24.40
2.5
1.7
ml
2252.3
1998.3
—
10
6
(3000850) Epithelial cells [#/volume] in Urine
153
669
2.85
23.82
2.7
2.2
e6/l
3.8
7.1
1.57
144
592
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
97
5.36
23.02
8.6
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
97
5.36
23.02
8.5
1.9
g/l
2.9
3.9
1.96
16
75
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
97
5.36
23.02
8.6
1.9
g/l
7.0
7.3
0.56
37
81
(21494814) CD8 cells/100 lymphocytes in Specimen
20
13
15.98
22.91
2.7
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
78
237
3.71
22.21
2.4
2.6
mmol/l
2.1
1.5
0.96
65
186
(3012544) pH of Venous blood
78
240
3.66
21.79
2.5
2.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
320
2065
2.51
21.50
5.3
4.0
mmol/l
6.1
6.5
5.83
309
1894
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
46
98
5.07
20.76
1.5
2.2
g/l
1.7
1.3
1.19
41
88
(3024471) HLA-A [Type]
26
9
30.36
19.83
1.0
1.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
356
2462
2.53
19.81
4.1
3.4
e6/l
716.2
1409.6
—
6
26
(3030981) Hyaline casts [#/volume] in Urine by Automated count
58
160
3.97
18.88
3.0
2.0
e6/l
0.0
0.2
1.48
58
152
(3018418) pH of Serum or Plasma
183
962
2.42
18.85
4.3
3.0
ph
7.4
7.4
0.34
19
176
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
90
5.00
18.81
8.7
1.9
g/l
2.2
2.9
2.01
17
77
(3009871) Measles virus Ab [Titer] in Serum
18
14
13.30
18.64
2.1
1.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
24
9
27.90
17.97
1.3
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
15
12.41
17.89
1.7
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
153
757
2.47
17.87
7.0
3.5
—
—
—
0
0
(3013512) EKG study
173
922
2.34
16.96
4.9
2.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
67
221
3.34
16.68
6.8
8.1
—
—
—
0
0
(3026782) Osmolality of Urine
132
630
2.48
16.52
2.9
2.2
mosm/kgh2o
571.7
576.9
0.10
122
541
(3007853) Bacteria identified in Skin by Aerobe culture
97
402
2.75
16.16
1.6
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
23
9.01
15.99
2.7
2.1
—
13.4
—
0
9
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
15
12
12.85
15.20
1.3
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
382
2882
2.35
15.12
14.4
6.5
u/l
70.3
73.6
1.38
374
2695
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
28
7.78
14.94
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
24
8.19
14.11
1.3
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
19
9.23
13.84
1.2
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
15
10.28
13.19
1.1
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
154
859
2.14
12.95
3.2
2.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
384
2986
2.21
12.84
3.4
2.8
u/l
36.6
41.6
1.16
372
2829
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
17
7
25.05
12.54
1.6
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
17
7
25.05
12.54
1.6
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
17
7
25.05
12.54
1.6
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
18
9
20.68
12.54
1.3
1.0
—
—
—
0
0
(4035726)
68
269
2.77
12.25
1.7
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
16
6
27.46
12.11
3.6
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
162
942
2.06
12.07
2.8
2.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
10
12.27
11.78
1.1
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
9
19.49
11.66
1.6
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
181
1110
1.99
11.53
3.0
2.7
mmol/l
2.3
2.4
2.13
163
995
(3032057) Clostridioides difficile [Presence] in Stool
14
5
28.73
10.77
1.9
2.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
102
516
2.23
10.76
1.4
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
26
60
4.52
10.64
1.7
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
26
64
4.23
9.82
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
61
4.26
9.54
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
27
6.09
9.17
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
263
1928
1.76
8.85
5.3
4.0
estimate
0.0
0.0
0.50
39
377
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
29
84
3.60
8.78
1.2
1.3
ug/l
3.3
3.4
0.02
29
78
(3009261) Glucose [Presence] in Urine by Test strip
265
1951
1.76
8.75
3.6
3.0
estimate
0.0
0.0
0.00
39
352
(3035350) Ketones [Presence] in Urine by Test strip
262
1929
1.75
8.60
3.5
2.9
estimate
0.0
0.0
0.00
39
370
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
84
429
2.15
8.56
3.4
3.8
%
29.6
31.5
0.78
67
290
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
78
388
2.20
8.48
2.2
1.9
%
25.4
25.1
0.07
71
342
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
30
5.48
8.25
1.3
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
82
421
2.13
8.23
2.2
1.8
g/l
2.3
2.4
1.26
77
394
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
88
3.44
8.20
11.4
2.0
g/l
6.9
10.4
3.51
24
83
(3042936) Bacteria identified in Isolate by Culture
85
446
2.09
8.05
1.9
1.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
21
6.33
7.75
1.3
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
464
4140
2.56
7.73
26.4
9.6
mg/l
22.5
21.0
0.46
413
3113
(3000494) Fungus identified in Specimen by Culture
85
454
2.05
7.67
3.4
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
0
+∞
7.31
1.6
0.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
246
1837
1.66
7.22
16.2
5.5
umol/l
9.3
10.9
3.38
239
1728
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
48
4.07
6.95
1.2
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
28
5.11
6.74
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
45
4.11
6.67
1.2
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
27
90
3.11
6.60
1.7
1.7
ug/l
272.2
228.9
0.12
22
82
(40761535) Cells panel - Urine sediment
57
278
2.18
6.48
3.1
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
114
712
1.78
6.33
3.5
2.3
ng/l
442.3
520.2
0.44
94
578
(3007164) IgA [Mass/volume] in Serum or Plasma
132
876
1.69
5.86
4.2
1.4
g/l
1.5
2.3
5.90
104
580
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
58
3.37
5.36
1.2
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
454
4132
2.01
5.26
25.5
10.4
mmol/l
3.9
3.9
1.02
447
4002
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
373
3217
1.62
5.21
4.1
3.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
434
3898
1.83
5.17
16.2
8.6
ml/min/173m2
81.1
89.7
11.39
369
3106
(3019550) Sodium [Moles/volume] in Serum or Plasma
452
4114
1.97
5.13
25.4
10.3
mmol/l
139.7
139.8
0.15
447
3998
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
76
2.98
5.09
3.0
2.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
60
3.25
5.09
1.2
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
16
46
3.56
4.93
2.1
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
32
138
2.41
4.86
3.8
2.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
25
96
2.69
4.80
1.1
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
7
11.59
4.80
1.1
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
26
112
2.39
3.99
1.5
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
26
112
2.39
3.99
1.5
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
153
1144
1.48
3.87
2.4
2.3
u/l
61.6
56.9
0.66
148
1060
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
173
1328
1.46
3.82
2.6
3.2
u/l
27.3
31.5
1.71
167
1261
(40768446) Kidney Pathology biopsy report
8
12
6.75
3.68
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
440
4055
1.68
3.66
12.0
10.5
%
39.4
41.0
4.06
362
3224
(3042631) Mycobacterium sp identified in Specimen
13
40
3.31
3.65
1.6
2.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
193
1531
1.42
3.52
2.1
2.1
nmol/l
79.1
74.7
1.36
182
1398
(3022217) INR in Platelet poor plasma by Coagulation assay
52
306
1.78
3.50
7.8
15.2
inr
1.1
1.3
0.55
20
49
(3003129) Base excess in Capillary blood by calculation
6
6
10.10
3.50
4.2
1.2
mmol/l
2.0
4.2
—
6
6
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
472
4457
1.96
3.35
16.8
8.4
u/l
25.1
28.0
4.43
465
4329
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
32
3.49
3.35
1.2
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
77
511
1.60
3.33
1.9
1.6
nmol/l
964.7
1223.6
2.37
68
391
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
19
4.80
3.25
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
68
2.55
3.07
3.4
2.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
29
147
2.03
3.06
2.1
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
219
1816
1.36
2.94
2.8
2.4
ug/l
241.5
100.7
2.55
211
1709
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
401
3668
1.46
2.93
4.1
4.6
mmol/mol
36.5
38.6
6.87
389
3467
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
30
3.38
2.92
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
30
3.38
2.92
1.2
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
58
2.63
2.90
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
428
3974
1.52
2.81
4.5
3.5
mmol/l
1.2
1.3
2.85
417
3735
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
23
3.96
2.78
1.0
1.0
miu/ml
907.8
1625.0
—
9
23
(3025941) Bacteria identified in Stool by Culture
38
219
1.80
2.77
1.1
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
6
8.40
2.75
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
6
8.40
2.75
2.6
2.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
25
126
2.04
2.70
1.1
1.8
—
153.3
—
0
6
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
112
843
1.42
2.65
2.0
1.7
mg/l
1.0
1.0
0.02
81
616
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
127
979
1.40
2.62
2.0
2.0
u/l
172.9
266.2
0.71
122
927
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
106
792
1.43
2.61
2.1
1.9
mg/l
2.8
2.9
0.07
88
668
(3022621) pH of Urine by Test strip
37
218
1.75
2.53
2.8
2.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
25
131
1.96
2.45
2.7
2.7
mmol/l
25.8
24.8
1.15
25
126
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
12
5.05
2.41
1.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
27
3.37
2.40
1.2
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
117
902
1.39
2.40
4.1
6.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
94
704
1.41
2.28
1.5
1.4
nmol/l
20.7
20.8
0.01
87
598
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
23
3.52
2.28
2.3
2.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
18
3.93
2.26
1.7
1.9
u/ml
1186.3
484.7
—
7
18
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
9
5.60
2.22
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
9
5.60
2.22
2.0
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
150
1220
1.33
2.16
3.7
2.7
ng/l
28.6
33.3
0.28
101
690
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
61
2.33
2.16
3.0
2.6
u/ml
0.3
0.3
—
9
30
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
49
2.48
2.12
1.2
1.4
pmol/l
49.4
57.4
—
6
12
(3004616) Nuclear Ab [Presence] in Serum
11
43
2.59
2.11
1.3
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
64
454
1.47
2.07
2.7
1.9
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
10
5.04
2.07
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
54
371
1.51
2.04
2.6
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
124
989
1.34
2.04
6.7
4.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
204
1745
1.28
2.00
6.3
7.8
e9/l
0.0
0.0
0.89
152
1445
(3026361) Erythrocytes [#/volume] in Blood
492
4789
2.25
1.98
32.7
14.7
e12/l
4.4
4.6
15.14
478
4675
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
165
1.74
1.95
1.8
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
11
4.58
1.94
1.4
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
8
27
2.99
1.94
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
16
3.78
1.94
1.2
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
10
39
2.60
1.93
1.1
1.3
u/l
44.6
50.6
—
5
25
(3010813) Leukocytes [#/volume] in Blood
492
4792
2.22
1.92
32.7
14.7
e9/l
6.2
6.6
3.22
478
4678
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
20
107
1.91
1.89
1.5
2.0
mg/l
12.6
10.5
0.37
20
102
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
28
2.89
1.87
1.3
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
31
191
1.66
1.86
1.0
1.4
miu/ml
128.5
259.6
1.20
11
99
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
17
3.56
1.84
1.0
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
491
4783
2.11
1.84
32.7
14.7
e9/l
234.3
254.4
8.79
475
4678
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
12
4.20
1.82
2.8
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
12
4.20
1.82
1.6
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
434
4118
1.39
1.80
4.1
3.8
mmol/l
1.5
1.5
0.50
421
3887
(40768441) Liver Pathology biopsy report
8
29
2.79
1.80
1.1
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
60
2.20
1.79
4.1
2.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
36
2.53
1.74
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
136
1125
1.29
1.70
3.1
2.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
55
2.21
1.68
1.1
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
90
1.92
1.67
1.5
1.3
ug/g
306.8
331.1
—
8
46
(40768804) Tissue Pathology biopsy report
173
1479
1.26
1.65
2.1
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
180
1546
1.26
1.65
3.5
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
434
4133
1.37
1.62
4.1
3.9
mmol/l
4.8
4.8
0.05
420
3914
(3021901) Oxygen saturation in Capillary blood
10
43
2.35
1.61
1.4
2.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
13
64
2.06
1.55
1.2
2.2
g/l
132.1
134.3
—
8
46
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
71
2.00
1.55
4.4
3.4
mg/l
18.2
19.9
—
8
39
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
45
318
1.46
1.53
1.4
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
37
2.46
1.48
1.1
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
52
696
0.72
1.47
1.3
1.3
iu/ml
39.1
32.2
0.13
14
234
(3011648) Oxygen content in Venous blood
7
28
2.52
1.45
2.6
1.5
%
13.0
12.0
—
7
28
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
22
2.75
1.44
2.0
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
6
22
2.75
1.44
1.2
1.1
u/l
42.5
30.3
—
6
15
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
6
22
2.75
1.44
1.2
1.1
u/l
104.0
122.6
—
6
15
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
40
2.27
1.40
2.0
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
436
4175
1.33
1.39
4.1
4.2
mmol/l
2.9
2.9
0.15
423
3939
(3014576) Chloride [Moles/volume] in Serum or Plasma
48
351
1.41
1.37
9.8
6.8
mmol/l
106.8
104.4
2.66
48
344
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
37
0.00
1.35
0.0
1.1
—
1.2
—
0
31
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
10
47
2.15
1.34
1.3
1.6
—
9.8
—
0
8
(3024928) Oxygen saturation in Venous blood
11
54
2.06
1.33
2.6
2.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
82
1011
0.77
1.32
1.2
1.3
u/ml
1.8
2.1
0.13
22
283
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
131
0.45
1.30
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
132
0.45
1.30
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
32
219
1.49
1.29
1.7
2.0
ug/l
18.6
8.4
0.48
26
199
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
44
2.06
1.27
1.3
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
40
543
0.71
1.24
3.7
2.4
mmol/l
2.4
2.4
0.67
35
484
(3017732) Neutrophils [#/volume] in Blood
37
264
1.43
1.22
2.2
2.6
e9/l
4.0
4.1
0.07
26
220
(3019150) Specific gravity of Urine by Refractometry
108
907
1.24
1.18
3.5
2.9
kg/l
1.0
1.0
0.14
14
112
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
130
0.46
1.17
1.2
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
7
30
2.35
1.12
1.4
1.2
nmol/l
30.3
31.9
—
7
24
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
73
1.80
1.11
1.2
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
12
66
1.84
1.10
1.0
1.0
u/ml
1.8
2.3
—
6
30
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
21
2.39
1.09
2.8
2.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
69
558
1.27
1.05
1.2
1.4
titre
328.0
506.2
—
10
113
(3003181) Sodium [Moles/volume] in Urine
7
34
2.07
1.03
1.1
1.3
mmol/l
57.9
72.3
—
7
29
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
284
0.66
1.01
1.3
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
9
48
1.89
1.01
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
155
1737
0.84
0.98
2.3
2.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
30
0.00
0.97
0.0
1.9
—
34.1
—
0
30
(3044889) 12 lead EKG panel
248
2674
0.86
0.96
2.7
3.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
62
1.79
0.95
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
299
3171
0.86
0.91
3.7
3.8
pmol/l
14.6
14.6
0.12
282
2917
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
153
0.58
0.90
1.6
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
29
2.08
0.89
1.3
1.6
—
—
—
0
0
(44790049)
8
42
1.92
0.89
1.9
1.5
—
—
—
0
0
(44790048)
8
42
1.92
0.89
1.9
1.5
—
—
—
0
0
(44806118)
8
42
1.92
0.89
1.9
1.5
—
—
—
0
0
(44790047)
8
42
1.92
0.89
1.9
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
310
2921
1.16
0.87
4.1
3.6
mm/h
11.7
9.3
2.33
289
2708
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
30
2.01
0.87
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
36
465
0.76
0.85
1.4
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
146
1.46
0.84
2.2
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
73
1.66
0.82
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
363
3781
0.86
0.81
4.0
4.4
mu/l
7.2
2.4
0.42
347
3528
(3002256) Pathology report gross observation
55
449
1.25
0.80
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
66
1.68
0.79
2.9
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
123
1.48
0.78
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
16
233
0.68
0.78
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
56
675
0.81
0.77
1.2
1.2
u/ml
13.0
11.4
0.05
20
284
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
77
656
1.21
0.76
1.4
1.6
pmol/l
210000409.2
15598345.1
0.70
70
577
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
24
2.09
0.74
1.6
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.4
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
25
2.01
0.73
1.4
3.2
%
109.8
96.8
—
5
25
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
86
744
1.19
0.73
2.7
2.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
84
1.56
0.72
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
94
821
1.18
0.71
2.9
2.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
145
0.61
0.70
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
168
0.65
0.68
1.5
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
27
1.86
0.68
2.2
1.3
—
—
—
0
0
(3020891) Body temperature
7
120
0.58
0.68
3.9
4.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
142
1286
1.15
0.67
2.1
1.8
pmol/l
98.1
98.0
0.00
99
661
(3032773) Endomysium IgG Ab [Titer] in Serum
7
44
1.60
0.65
1.1
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
44
1.60
0.65
1.0
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
175
0.68
0.61
1.7
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
43
354
1.23
0.61
2.3
2.2
nmol/l
13.3
13.9
0.20
38
330
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
22
0.00
0.59
0.0
5.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
22
0.00
0.59
0.0
3.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
309
0.77
0.59
1.0
1.2
iu/ml
224.8
148.1
—
8
128
(3015171) Extractable nuclear Ab [Units/volume] in Serum
11
161
0.68
0.58
1.2
1.2
—
1.6
—
0
6
(3049717) Cytology report of Urine Cyto stain
14
98
1.44
0.57
3.2
2.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
36
1.67
0.57
1.7
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
73
1.52
0.56
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
37
1.63
0.55
1.7
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
26
326
0.79
0.53
1.5
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
97
0.61
0.52
1.5
1.2
mmol/l
4.0
3.7
—
6
90
(40761511) CBC panel - Blood by Automated count
454
4458
1.19
0.52
23.8
9.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
116
1057
1.13
0.51
3.8
3.1
estimate
0.0
0.0
1.08
35
365
(4034850)
10
144
0.69
0.50
4.7
8.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
199
0.75
0.47
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
68
1.48
0.47
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
46
534
0.85
0.47
1.5
1.6
—
—
—
0
0
(4010399)
21
265
0.78
0.47
1.3
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
25
201
1.26
0.46
4.0
2.4
u/ml
70.5
36.4
0.26
25
196
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
79
878
0.88
0.45
3.4
3.6
%
23.4
21.7
0.39
40
362
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
230
0.77
0.44
3.9
2.3
u/l
15.7
3898.0
—
6
97
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
30
248
1.22
0.44
2.5
3.5
pmol/l
4.3
4.6
1.66
25
222
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
38
322
1.19
0.44
1.5
1.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
31
1.62
0.43
1.0
1.1
—
5.3
—
0
8
(3035285) Chloride [Moles/volume] in Venous blood
5
32
1.57
0.42
2.6
2.0
mmol/l
105.6
106.0
—
5
32
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
32
1.57
0.42
2.6
2.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
32
1.57
0.42
2.6
2.0
mmol/l
4.1
3.9
—
5
32
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
57
1.41
0.42
1.0
1.1
g/l
1.7
1.4
—
8
51
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
33
1.52
0.41
1.6
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.4
—
157.0
—
0
16
(3020650) Glucose [Presence] in Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
8.2
—
0
17
(3023419) Bacteria identified in Sputum by Culture
5
34
1.48
0.40
1.0
2.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
34
1.48
0.40
1.6
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
3.8
—
7.8
—
0
18
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
124
1.30
0.39
1.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
36
308
1.18
0.38
10.7
7.9
mmol/l
0.5
0.8
0.28
30
237
(40761536) Microorganisms panel - Urine sediment
30
354
0.84
0.38
3.8
3.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
9
68
1.33
0.38
4.3
4.0
umol/l
49.7
35.6
—
9
56
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
22
267
0.82
0.37
1.3
1.2
—
54.4
—
0
15
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
793
0.89
0.37
1.3
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
30
255
1.19
0.35
12.3
6.7
mmol/l
1.1
1.3
1.18
30
249
(40768793) Breast Pathology biopsy report
6
86
0.69
0.33
1.7
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
96
1034
0.91
0.33
1.5
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
192
1.21
0.32
1.3
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
220
1.19
0.32
1.3
1.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
137
1.25
0.32
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
137
1.25
0.32
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
31
355
0.86
0.29
1.1
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
17
139
1.23
0.29
2.2
2.1
%
0.7
0.7
0.00
17
134
(4094501)
8
108
0.74
0.29
1.3
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
76
1.32
0.28
1.0
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
46
414
1.12
0.27
2.6
2.9
umol/l
8.3
6.4
0.28
39
359
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
59
644
0.91
0.27
2.6
2.6
ug/l
0.8
0.7
0.47
45
377
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
141
1.21
0.26
1.5
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
72
0.69
0.26
1.8
4.1
e9/l
5.4
4.1
—
5
72
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
73
0.68
0.26
1.8
4.6
%
65.2
57.8
—
5
73
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
77
1.17
0.24
1.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
58
629
0.91
0.24
1.3
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
82
0.73
0.24
5.2
3.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
19
222
0.85
0.24
1.1
1.6
mg/l
3.9
2.7
0.37
11
157
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
401
3953
1.07
0.23
5.3
3.8
mmol/l
5.6
5.8
4.79
385
3684
(3016018) Differential panel - Cerebral spinal fluid
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(4062490)
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
16
135
1.19
0.21
1.1
1.6
g/l
0.2
0.2
1.22
16
127
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.9
—
16.2
—
0
11
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.2
—
1.9
—
0
11
(3035880) pH of Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
5.7
—
0
10
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
11.8
—
0
12
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
73.8
—
0
12
(4133840)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
126
1.20
0.21
1.3
2.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
13
0.00
0.21
0.0
3.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
80
1.26
0.20
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
1.2
—
0
9
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
133
0.82
0.19
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
133
0.82
0.19
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
154
0.84
0.19
2.3
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
137
1.17
0.19
1.1
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
14
119
1.18
0.18
1.3
1.3
—
66.4
—
0
14
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
243
1.12
0.17
1.6
1.3
iu/l
26.5
24.5
0.12
19
210
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
66
0.76
0.17
1.0
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
76
0.79
0.15
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
78
0.77
0.15
1.2
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
140
1.15
0.15
1.1
1.6
g/l
1.1
1.2
1.05
16
132
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
256
1.10
0.14
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
98
0.81
0.14
1.8
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
28
258
1.09
0.12
2.6
4.4
ug/l
139.5
5.3
0.48
22
206
(3048689) Calprotectin [Mass/mass] in Stool
54
568
0.94
0.12
2.0
2.5
ug/g
99.3
127.5
0.41
45
448
(3002385) Erythrocyte distribution width [Ratio]
364
3604
1.04
0.11
13.7
11.9
%
13.3
13.4
0.82
359
3534
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
31
332
0.93
0.11
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
134
1.12
0.11
1.3
2.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
48
504
0.95
0.10
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
44
1.14
0.10
1.0
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
106
1.14
0.10
2.1
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
145
1.11
0.09
17.4
10.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
84
1.07
0.07
1.7
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
100
1022
0.97
0.06
1.6
1.6
mmol/l
1.4
1.4
0.07
91
879
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
444
1.04
0.06
4.7
5.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
220
0.95
0.03
1.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
290
1.04
0.03
1.3
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
148
0.94
0.02
1.6
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
272
1.03
0.02
1.3
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
60
609
0.98
0.02
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
30
293
1.03
0.01
1.3
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
41
417
0.98
0.01
1.2
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
18
174
1.04
0.00
2.8
5.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
186
0.97
0.00
1.5
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
30
294
1.02
0.00
1.3
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
245
0.98
0.00
1.1
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
375
1.01
0.00
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
58
585
0.99
0.00
3.0
2.9
ng/l
243.4
394.2
0.26
39
382
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
213
0.99
0.00
2.0
1.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
172
0.99
0.00
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
172
0.99
0.00
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
172
0.99
0.00
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
172
0.99
0.00
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
151
0.99
0.00
4.2
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
29
289
1.00
0.00
1.3
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
59
1.02
0.00
4.3
2.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
7.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
7.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
69
0.87
0.00
2.8
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.8
—
613.8
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
53.5
—
0
7
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
71
0.99
0.00
2.0
1.9
%
13.3
13.1
—
7
71
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
72.0
—
0
8
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
74
0.95
0.00
2.0
1.9
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
8.8
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
89
0.90
0.00
1.4
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_DONORS_ORGANS_TISSU – Donors of organs and tissues
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).